References
- Aamdal S., Børmer O., Jørgensen O., et al. Estrogen receptors and long term prognosis in breast cancer. Cancer 1984; 53: 2525
- Auer G., Caspersson T., Wallgren A. DNA content and survival in mammary carcinoma. Anal. Quant. Cytol. 1980; 2: 161
- Eriksson E., Azavedo E., Caspersson T., Wallgren A. Prognostic significance of nuclear DNA content in mammary adenocarcinomas in humans. Cancer Res. 1984; 44: 394
- Benson E. A., Cartwright R. A., Cowen P. N., Hamilton J. Oestrogen recptors and survival in early breast cancer. Brit. Med. J. 1982; 284: 597
- Burton K. A. A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochem. J. 1956; 62: 315
- Fallenius A., Skoog L., Svane G., Auer G. Histopathology, nuclear DNA content and steroid receptors in 50 non-palpable, mammographically detected breast carcinomas. Cytometry 1984; 5: 426
- Godolphin W., Elwood J. M., Spinelli J. J. Estrogen receptor quantitation and staging as complementary prognostic indicators in breast cancer. A study of 583 patients. Int. J. Cancer 1981; 28: 677
- Howat J. M. T., Harris M., Swindell R., Barnes D. M. The effect of oestrogen and progesterone receptors on recurrence and survival in patients with carcinoma of the breast. Brit. J. Cancer 1985; 51: 263
- Killander D., Borg Å., Ewers S. B. Ploidly and estrogen receptor status in relation to prognosis in breast cancer stage II. Third EORTC breast cancer working conference. Abstract No. VI, 25. 1983
- Kinne D. W., Ashikari R., Butter A., Menendez-Botet C., Rosen P. P., Schwartz M. Estrogen receptor protein in breast cancer as a predictor of recurrence. Cancer 1981; 47: 2364
- Klintenberg C., Stål O., Nordenskjöld B., Wallgren A., Arwidsson S., Skoog L. Proliferative index, cytosol estrogen receptors and axillary node status as prognostic predictors in human mammary carcinoma. Breast Cancer Res. and Ther., in press 1986
- Wallgren A., Bjelkenkrantz K., et al. DNA distribution, cytosol estrogen receptors and axillary nodes as prognostic predictors in breast carcinoma. Acta Radiol. Oncology 1985; 24: 253
- Mason B. H., Holdaway I. M., Mullins P. R., Yee L. H., Kay R. G. Progesterone and estrogen receptors as prognostic variables in breast cancer. Cancer Res. 1983; 43: 2985
- Parl F., Schmidt P., Dupont W., Wagner R. Prognostic significance of estrogen receptor status in breast cancer in relation to tumor stage, axillary node metastases and histopathologic grading. Cancer 1984; 54: 2237
- Silfverswärd C., Humla S. Estrogen receptor analysis on needle aspirates from human mammary carcinoma. Acta Cytol. 1980; 24: 54
- Stewart J. F., King R. J. B., Sexton S. A., Millis R. R., Rubens R. D., Hayward J. L. Steroid receptors and prognosis in operable (stage I and II) breast cancer. Europ. J. Cancer Clin. Oncol. 1983; 19: 1381
- Tabàr L., Fagerberg C. J. G., Gad A., et al. Reduction in mortality from breast cancer after mass screening with mammography. Lancet 1985; I: 829
- Theve N. O., Carlström K., Gustafsson J., et al. Oestrogen receptors and peripheral serum levels of oestradiol-17-β in patients with mammary carcinoma. Europ. J. Cancer 1978; 14: 1337
- Wallgren A., Baral E., Glas U., . Adjuvant breast cancer treatment with tamoxifen and combination chemotherapy in postmenopausal women. Adjuvant therapy of cancer. III, S. E. Salmon, S. E. Jones, et al. Grune and Stratton, New York 1981
- Westerberg H., Gustafsson S. A., Nordenskjöld B., Silfversward C., Wallgren A. Estrogen receptor level and other factors in early recurrence of breast cancer. Int. J. Cancer 1980; 26: 429
- Wrange Ö., Nordenskjöld B., Gustavsson J. Cytosol estradiol receptor in human mammary carcinoma. An assay based on isoelectric focusing on polyacrylamide gel. Anal. Biochem. 1978; 85: 461